Product Information
LAMICTAL 200 MG TABLET is a brand product labeled by GlaxoSmithKline LLC, priced at $12.0575 per EA under NDC 00173064460. Its NADAC has been published 665 times since Nov 28, 2013.
FDA first approved this application on Dec 27, 1994. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The High Outlier badge above means this manufacturer's average price in the lamotrigine market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
200 mg/1
Manufacturer
GlaxoSmithKline LLCNDC
00173064460
Classification
Brand
Dosage Form
TABLET
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
LAMOTRIGINEApproval Type
New Drug (NDA)
FDA Application
NDA020241FDA Approved
12/27/1994
TE Code
AB
On Market Since
1/18/1995
Pharmacological Classes
Price Statistics
The NADAC for LAMICTAL 200 MG TABLET has been published 665 times since Nov 28, 2013, and over the history we have for it it has risen 41.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $12.0575 per EA |
|---|---|
| All-time high | $20.8537 (Oct 11, 2023) |
| All-time low | $8.4986 (Nov 28, 2013) |
| 52-week high | $12.0813 |
| 52-week low | $12.0569 |
| Median price | $15.1073 |
| Average price | $14.9241 |
| Largest weekly change | -43.5% (Dec 27, 2023) |
| Weeks tracked | 665 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of LAMICTAL 200 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for LAMICTAL 200 MG TABLET, manufactured by GlaxoSmithKline LLC, is $12.0575 per EA (NDC 00173064460), effective Aug 19, 2026.
How has the price of LAMICTAL 200 MG TABLET changed over time?
Over the history we have for it, the NADAC for LAMICTAL 200 MG TABLET has risen 41.9%. It has been tracked across 665 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for LAMICTAL 200 MG TABLET?
Since Nov 28, 2013, the NADAC for LAMICTAL 200 MG TABLET has ranged from a low of $8.4986 (Nov 28, 2013) to a high of $20.8537 (Oct 11, 2023), with a median of $15.1073 per EA.
Are there cheaper alternatives to LAMICTAL 200 MG TABLET?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as LAMICTAL 200 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures LAMICTAL 200 MG TABLET?
LAMICTAL 200 MG TABLET (NDC 00173064460) is labeled by GlaxoSmithKline LLC, and CMS classifies it as a brand product.